2014 AC: New Lifestyle and Business Enabled by Emerging Technology

Time:
11:30 – 12:30 pm Registration/Networking, Free Lunch Provided
12:30 – 5:00 pm Speeches and Panel Discussions
5:15 – 9:00 pm Banquet, Keynote Speech and Music Performance, Raffle Drawing

Conference Synopsis

TAITA-SV will host its 2014 annual conference on Saturday, May 10, 2014 in San Jose. The theme for this year’s annual conference is New Lifestyle and Business Enabled by Emerging Technology. Particularly, we focus on the emerging technology arenas and disruptive business models that have a high potential to change our lifestyle and reshape the industry value chains.

The 2014 TAITA-SV Annual Conference will be featured with three outstanding afternoon guest speakers with distinctive venture capital industry-leading track records in their respective major regions of business practices, namely, Silicon Valley and Taiwan. They will share their key insights and provide a high-level guidance for the likely technology business evolutions over the next 5 years. A new “On-Stage Sofa Chat” format is being adopted this year at our annual conference to better promote thought-provoking discussions among the speakers and audiences. Additionally, two Panels will be offered to address 1. Wearable Devices: Impact and Opportunity to be moderated by Dr. Huang Lee, and 2. From Engineer to Technical Lead/Manager to be moderated by Dr. Kelin Lee. The first panel aims to provide a refreshing perspective on the fast emerging Wearable Devices industry sector, and the second panel aspires to help younger engineering professionals who intend to migrate from the engineering to management track in their future career paths.

The 2014 AC will culminate at the evening banquet keynote speech by Rongjin Lin, who currently holds the position at TTY Biopharm Co., Ltd. in Taiwan as Chairman & CEO. Mr. Lin also held several chief executive management roles in various pharmaceutical and medical device companies for over the past 30 years. Mr. Lin is specializing in company re-structuring and building pharmaceutical business strategy and establishing strategic management. From a traditional generic pharmaceutical company to a new drugs development biotech pharmaceutical company, Mr. Lin has been leading TTY through various difficult restructuring stages and helped TTY to become the first restructured local pharmaceutical company in Taiwan. He drove TTY to be listed as a public company and trade- over-counter under the Biotechnology Industry session of Taiwan stock market. Mr. Lin has also been actively participating in the formation of many medical device start-ups in both Taiwan and Silicon Valley.

Program Highlight [1]

11:30~12:30pm

Registration and Networking /Complimentary Lunch Provided

12:30~12:40pm

Opening Remarks, VIP Addresses

12:40~1:10pm

Speech by Mr. Hans Tai, (戴逸之)

"The Crossroad of Taiwan High Tech and Venture Investment"

General Partner of InnoBridge Venture Capital Fund and Chairman of VBridge Technology, Inc.

1:10~1:50pm

On-Stage Sofa Chat Among Cross Pacific VCs
Coordinator: Jackie Yang, Translink Capital

Dr. Wen Hsieh, Kleiner Perkins Caufield Byers

Mr. Hans Tai, Innobridge Venture Capital Fund

1:50~2:10pm

Break/Refreshment

2:10~3:30pm

Panel “Wearable Devices: Impact and Opportunity”

Moderator

Dr. Huang Lee

Panelists

1) Dr. Yan Chow, MD, MBA, Director of Innovation and Advanced Technology, Kaiser Permanente Information Technology

2) Dr. Wayne Dai, CEO of Verisilicon Inc.

3) Dr. Jin Lee, CTO of Salutron

4) Mr. Sam Massih, Director of Wearable Sensors at InvenSense

3:30~3:45pm

Break/Refreshment

3:45~5:00pm

Panel “From Engineer to Technical Lead/Manager”

Moderator

Dr. Kelin Lee

Panelists [2]

1) Mr. Chris Cheng, Director at Samsung

2) Dr. Lichun Huang, Senior Scientist at Genentech-Roche

3) Dr. Randy Huang, Director at Tabula Inc

4) A.J. Hunyady, Senior Director at Gigamon Systems

5:00~5:15pm

TAITA-SV Member General Meeting

5:15~5:45pm

Banquet Check-in and Networking

5:45~7:00pm

Dinner

7:00~7:30pm

Remarks by TAITA Presidents, Recognition of Sponsors, Transition of BOD

7:30~8:30pm

Keynote Speech

Status and Outlook for Taiwan's Burgeoning Biotech Industry

台灣生技產業發展動向及趨勢

Dr. Rongjin Lin林榮錦董事長

Chairman & CEO of TTY Biopharm (東洋製藥集團)

8:30~9:00pm

Music program by V.K Ke (V.K克,《蘭陵王》片尾曲「手掌心」作曲/製作)

9:00 pm

Closing Remarks

[1] Tentative Program, subject to refinements, please visit www.taita.us for the updated program.

[2] Panelists will share their life experiences and do not represent their current companies.